Acadia Pharmaceuticals buy Bank of America Co.
Start price
25.03.26
/
50%
€19.04
Target price
25.03.27
€24.99
Performance (%)
36.87%
Price
18.08.26
€26.06
Summary
This prediction is currently active. With a performance of 36.87% the BUY prediction by Bank_of_America_Co_ is a big success. This prediction currently runs until 25.03.27. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | -1.649% | -1.649% |
| iShares Core DAX® | -0.046% | 5.960% |
| iShares Nasdaq 100 | 0.922% | 3.693% |
| iShares Nikkei 225® | 3.014% | 6.638% |
| iShares S&P 500 | -0.359% | 2.747% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (ACAD) was upgraded by Bank of America Corporation from "neutral" to "buy". They now have a $29.00 price target on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€22.15
30.06.26
30.06.26
€26.32
30.06.27
30.06.27
17.65%
18.08.26
18.08.26
